⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99)

Official Title: A Phase 2 Study to Evaluate the Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Etoposide and Cisplatin or Carboplatin for the First-Line Treatment of Participants With Extensive-Stage Small Cell Lung Cancer (KEYNOTE-B99)

Study ID: NCT04924101

Study Description

Brief Summary: The purpose of this study is to evaluate the use of investigational agents (MK-4830, boserolimab (MK-5890) and lenvatinib (MK-7902)) in combination with pembrolizumab (MK-3475) and etoposide/platinum chemotherapy for the first-line treatment of participants with extensive-stage small cell Lung Cancer (ES-SCLC). No formal hypothesis testing will be performed for this study.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Banner MD Anderson Cancer Center ( Site 0102), Gilbert, Arizona, United States

University of Colorado Anschutz Medical Campus ( Site 0104), Aurora, Colorado, United States

Georgia Cancer Specialists ( Site 0106), Atlanta, Georgia, United States

Parkview Research Center at Parkview Regional Medical Center ( Site 0130), Fort Wayne, Indiana, United States

Baptist Health Lexington-Research ( Site 0108), Lexington, Kentucky, United States

MFSMC-HJWCI-Oncology Research ( Site 0128), Baltimore, Maryland, United States

Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0122), Omaha, Nebraska, United States

Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0129), Omaha, Nebraska, United States

Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0114), Mineola, New York, United States

Memorial Sloan Kettering Cancer Center ( Site 0115), New York, New York, United States

Cleveland Clinic-Taussig Cancer Center ( Site 0116), Cleveland, Ohio, United States

UPMC Hillman Cancer Center ( Site 0127), Pittsburgh, Pennsylvania, United States

St Francis Cancer Center-Research Office ( Site 0117), Greenville, South Carolina, United States

Virginia Cancer Institute ( Site 0119), Richmond, Virginia, United States

Klinik Penzing-2. Lungenabteilung ( Site 2101), Vienna, Wien, Austria

Klinik Floridsdorf-Abteilung für Innere Medizin und Pneumologie ( Site 2100), Wien, , Austria

Hamilton Health Sciences-Juravinski Cancer Centre ( Site 2003), Hamilton, Ontario, Canada

Kingston Health Sciences Centre-Kingston General Hospital Site ( Site 2005), Kingston, Ontario, Canada

St. Marys Hospital Center ( Site 2000), Montreal, Quebec, Canada

Jász-Nagykun-Szolnok Megyei Hetényi Géza Kórház-Onkologiai Kozpont ( Site 2800), Szolnok, Jasz-Nagykun-Szolnok, Hungary

Országos Korányi Pulmonológiai Intézet-XIV. Tüdöbelgyógyászat ( Site 2806), Budapest, Pest, Hungary

Torokbalint Tudogyogyintezet-Onkopulmonologiai Jarobeteg Centrum ( Site 2801), Törökbálint, Pest, Hungary

Zala Megyei Szent Rafael Kórház-Pulmonológia ( Site 2805), Zalaegerszeg, Zala, Hungary

Semmelweis University-Pulmonológiai Klinika ( Site 2802), Budapest, , Hungary

Rambam Health Care Campus-Oncology ( Site 2600), Haifa, , Israel

Shaare Zedek Medical Center ( Site 2602), Jerusalem, , Israel

Meir Medical Center ( Site 2601), Kfar Saba, , Israel

Rabin Medical Center-Oncology ( Site 2604), Petah Tikva, , Israel

Sheba Medical Center-ONCOLOGY ( Site 2603), Ramat Gan, , Israel

Ospedale San Raffaele-Oncologia Medica ( Site 2303), Milano, Lombardia, Italy

ospedale le scotte-U.O.C. Immunoterapia Oncologica ( Site 2300), Siena, Toscana, Italy

Istituto Europeo di Oncologia IRCCS-Divisione di Oncologia Toracica ( Site 2304), Milano, , Italy

Chungbuk National University Hospital ( Site 1107), Cheongju-si, Chungbuk, Korea, Republic of

Seoul National University Bundang Hospital ( Site 1104), Seongnam, Kyonggi-do, Korea, Republic of

The Catholic University Of Korea St. Vincent's Hospital ( Site 1106), Suwon-si, Kyonggi-do, Korea, Republic of

Seoul National University Hospital ( Site 1101), Seoul, , Korea, Republic of

Severance Hospital, Yonsei University Health System-Medical oncology ( Site 1105), Seoul, , Korea, Republic of

Asan Medical Center-Department of Oncology ( Site 1103), Seoul, , Korea, Republic of

Samsung Medical Center ( Site 1100), Seoul, , Korea, Republic of

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier, Warszawa, Mazowieckie, Poland

Samodzielny Publiczny Zespó Grulicy i Chorób Puc w Olsztynie-Oddzial Onkologii z Pododdzialem Chemi, Olsztyn, Warminsko-mazurskie, Poland

Krasnoyarsk Regional Oncology Dispensary, Named after Krizhanovsky ( Site 2708), Krasnoyarsk, Krasnoyarskiy Kray, Russian Federation

N.N.Petrov Research Institute of Oncology-Department of Chemotherapy and Innovative Technologies ( S, Saint Petersburg, Sankt-Peterburg, Russian Federation

GBUZ "SPb CRPCstmc(o)" ( Site 2705), Saint-Petersburg, Sankt-Peterburg, Russian Federation

Scientific research institution of oncology named after N.N. Petrov-Thoracic oncology ( Site 2704), Sankt-Peterburg, , Russian Federation

Instituto Catalan de Oncologia - Hospital Duran i Reynals ( Site 2403), L'Hospitalet de Llobregat, Cataluna, Spain

Hospital Insular de Gran Canaria ( Site 2402), Las Palmas de Gran Canaria, Las Palmas, Spain

Hospital Universitari Vall d'Hebron-Oncology ( Site 2401), Barcelona, , Spain

Cantonal Hospital St.Gallen-Oncology & Hematology ( Site 2502), st.Gallen, Sankt Gallen, Switzerland

Contact Details

Name: Medical Director

Affiliation: Merck Sharp & Dohme LLC

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: